• 375 pages • 381 Exhibits • 60 Company Profiles • Report #S251
PUBLISHED December 2015
EXECUTIVE SUMMARY (only) —
This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments, and others. The report details current clinical and technology developments in the worldwide market, providing a current assessment of products in development and on the market; market size and forecast; competitor market shares; 60 competitor profiles; and an assessment of the market opportunity for current and hopeful competitors.
The report provides full year (actual) 2014 market size and share data, with forecast market data to 2024, for the Americas (with detail for U.S., Rest of North America and Latin America), Europe (with detail for United Kingdom, Germany, France, Spain, Italy, and Rest of Europe), Asia/Pacific (with detail for Japan, Korea, and Rest of Asia/Pacific) and Rest of World.
This report details the current and projected market for wound management products, including traditional adhesive, traditional gauze, non-adherent, film, foam, hydrogel, hydrocolloid, alginate, antimicrobial, negative pressure wound therapy (NPWT), bioengineered skin & skin substitution, growth factors. Emphasis is placed on emering technologies demonstrating clinical efficacy (e.g., bioengineered skin & skin substitutes, and wound growth factors), while baseline data (current and forecast market size and current competitor market shares per country) are provided for well established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, and physical treatments. The report details the clinical and technology developments underlying the clinical practice and market development in wound care, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., rest of North America, Latin America, leading western European countries (specifically, United Kingdom, Germany, France, Italy, Spain), rest of Europe, Japan, Korea, rest of Asia/Pacific, and the Rest of World category. The report’s company profiles assess leading and key emerging companies regarding current/projected products, technologies and positions in the advanced wound care market.
See the table of contents and list of exhibits for the full Wound Management report s251 at link.
MedMarket Diligence Reports are produced through primary and secondary research. Primary research includes interviews with clinicians, industry representatives, and other stakeholders in the market for their knowledge and insights on product development, market development, clinical practice and trends associated with the evolving use of technologies. Secondary data includes SEC filings; company annual reports; regional, federal, and international datasets; brokerage other investment reports; and other independent market research is used to corroborate and support assessments and projections. Reports are written and researched by industry insiders, whose familiarity with the companies, industry dynamics and other marketplace specifics facilitate the research process and ensure high quality and thorough reports.
Or, fax yourorder form.
Refund Policy: MedMarket Diligence print products are refundable if returned in salable condition within 30 (thirty) days of purchase date. Electronic products (PDF, online database subscription) are non-refundable; clients are urged to review content on mediligence.com or contact MedMarket Diligence directly via phone or email in advance of purchase to ensure that electronic products will meet customer needs.